Correlation Between Viridian Therapeutics and Mutares SE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Mutares SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Mutares SE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and mutares SE Co, you can compare the effects of market volatilities on Viridian Therapeutics and Mutares SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Mutares SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Mutares SE.

Diversification Opportunities for Viridian Therapeutics and Mutares SE

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Viridian and Mutares is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and mutares SE Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on mutares SE and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Mutares SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of mutares SE has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Mutares SE go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Mutares SE

Assuming the 90 days trading horizon Viridian Therapeutics is expected to under-perform the Mutares SE. In addition to that, Viridian Therapeutics is 1.88 times more volatile than mutares SE Co. It trades about -0.01 of its total potential returns per unit of risk. mutares SE Co is currently generating about 0.01 per unit of volatility. If you would invest  2,285  in mutares SE Co on August 31, 2024 and sell it today you would earn a total of  0.00  from holding mutares SE Co or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Viridian Therapeutics  vs.  mutares SE Co

 Performance 
       Timeline  
Viridian Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Viridian Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Viridian Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
mutares SE 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days mutares SE Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Viridian Therapeutics and Mutares SE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viridian Therapeutics and Mutares SE

The main advantage of trading using opposite Viridian Therapeutics and Mutares SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Mutares SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mutares SE will offset losses from the drop in Mutares SE's long position.
The idea behind Viridian Therapeutics and mutares SE Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Global Correlations
Find global opportunities by holding instruments from different markets